REVOLO BIOTHERAPEUTICS

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing and without suppression of the immune system. Its mission is to revolutionize autoimmune and allergic disease treatment by resetting the immune system for superior long-term disease remission. Revolo Biotherapeutics was founded in 2011 and formerly known as Immune Regulation.

#SimilarOrganizations #People #Financial #Event #Website #More

REVOLO BIOTHERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Life Science

Founded:

2011-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.revolobio.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

52.05 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA V2 Digital Ocean Gandi.net DNS

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system

Current Advisors List

dominik-escher_image

Dominik Escher Chairman @ Revolo Biotherapeutics
Board_member

isaac-cheng_image

Isaac Cheng Non-Executive Board Director @ Revolo Biotherapeutics
Board_member

Current Employees Featured

roly-foulkes_image

Roly Foulkes
Roly Foulkes Chief Scientific Officer @ Revolo Biotherapeutics
Chief Scientific Officer

jonathan-m-rigby_image

Jonathan M. Rigby
Jonathan M. Rigby President & CEO @ Revolo Biotherapeutics
President & CEO
2020-04-01

valerie-corrigall_image

Valerie Corrigall
Valerie Corrigall Group Discovery Leader @ Revolo Biotherapeutics
Group Discovery Leader

jonathan-gold_image

Jonathan Gold
Jonathan Gold Chief Financial Officer @ Revolo Biotherapeutics
Chief Financial Officer
2021-01-01

perry-calias_image

Perry Calias
Perry Calias Chief Operations Officer @ Revolo Biotherapeutics
Chief Operations Officer
2021-02-01

Investors List

24-haymarket_image

24 Haymarket

24 Haymarket investment in Series B - Revolo Biotherapeutics

metellus_image

Metellus

Metellus investment in Series B - Revolo Biotherapeutics

morningside-technology-ventures_image

Morningside Venture Investments

Morningside Venture Investments investment in Series B - Revolo Biotherapeutics

24-haymarket_image

24 Haymarket

24 Haymarket investment in Series A - Revolo Biotherapeutics

ncl_image

NCL Technology Ventures

NCL Technology Ventures investment in Series A - Revolo Biotherapeutics

Key Employee Changes

Date	New article
2020-03-27	Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer

Official Site Inspections

http://www.revolobio.com Semrush global rank: 4.44 M Semrush visits lastest month: 2.48 K

Host Informations
Whois Informations

Loading ...

More informations about "Revolo Biotherapeutics" on Search Engine